Hardean E. Achneck is Member of American Heart Association, Inc., Member of The International Society of Thrombosis & Hemostasis, Member of The European Society of Cardiology, Member of American Society of Gene & Cell Therapy and Vice President & Head-Medical Development at Dicerna Pharmaceuticals, Inc.

In his past career Hardean E. Achneck was Chief Medical Officer of Hemostemix, Inc.

Dr. Achneck received an undergraduate degree from Yale University and a doctorate from Yale School of Medicine.